Cleared Traditional

K022109 - EIZO

K022109 is the FDA 510(k) clearance for EIZO by Eizo Nanao Corporation. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K022109 · Eizo Nanao Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2002
Decision
14d
Days
Class 2
Risk

K022109 is an FDA 510(k) clearance for the EIZO, MODEL FC-2091. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Eizo Nanao Corporation (Ishikawa 924-8566, JP). The FDA issued a Cleared decision on July 12, 2002 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Eizo Nanao Corporation devices

Submission Details

510(k) Number K022109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2002
Decision Date July 12, 2002
Days to Decision 14 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 107d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Tuv Rheinland of North America, Inc.
WOLFRAM GMELIN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K022109.
QUANTITATIVE BLOOD POOL SPECT (QBS)
K022428 · Adac Laboratories · Aug 2002
ADVANTAGE WINDOWS X-RAY/MR FUSION
K022310 · Ge Medical Systems, Inc. · Aug 2002
MEDICAL ADMINISTRATOR
K020073 · Barco N.V. · Jul 2002
SCEPTRE-VS
K021314 · Hitachi Medical Systems America, Inc. · Jul 2002
Q LAB SOFTWARE
K021966 · Advanced Technology Laboratories, Inc. · Jul 2002
PHYSICIAN'S DESKTOP REVIEW
K021669 · Adac Laboratories · Jun 2002